Coronavirus BRIEFING
Supported by Essilor

Crisis Response Tactics

Do I Have a Cold or COVID? Does It Matter?

By Staff
Wednesday, July 24, 2024 7:59 AM The summer COVID-19 bump is here, and growing, but there’s some relatively good news, too. For many, the symptoms don’t last nearly as long as they once did.

Depression or Long COVID? Understanding the Overlapping Symptoms

By Staff
Tuesday, July 23, 2024 7:59 AM In 2021, Emma Javits, 35, thought she was going through a really, really bad depressive episode: She was barely able to get out of bed and do basic tasks. It took 3 years to figure out that her debilitating fatigue was due to long COVID, not just depression.

Biden Has COVID and Didn't Wear a Mask: CDC Guidelines Say He Doesn't Have to

By Staff
Monday, July 22, 2024 6:09 AM President Biden did not wear a face mask in public a couple of times after the White House announced he had tested positive for COVID-19opens in a new tab or window. The White House said the Democratic incumbent was experiencing "mild" symptoms while the president's physician said Biden would self-isolate "in accordance with CDC guidance for symptomatic individuals."

Long COVID Risk Has Fallen, Largely Attributable to Vaccine Rollout

By Staff
Monday, July 22, 2024 6:09 AM The risk of developing long COVID, or post-acute sequelae of COVID-19 (PASC), has decreased substantially over the course of the pandemic, according to an analysis of Veterans Affairs data.

Long COVID Risk Has Dropped Since Start of Pandemic

By Staff
Friday, July 19, 2024 7:59 AM Your chances of developing long COVID have significantly decreased since the pandemic began, offering a glimmer of hope and a sign of progress in the ongoing battle against the virus.

Scientist Homes in on Long COVID's Neuro Impacts

By Staff
Thursday, July 18, 2024 8:02 AM Neurologic symptoms of long COVID are vast, common, hard to treat, disabling, and can mimic dozens of other syndromes, with some symptoms as serious as those seen in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and postural orthostatic tachycardia syndrome (POTS).

COVID May Affect Type 1 Diabetes in Kids, and Not in a Good Way

By Staff
Tuesday, July 16, 2024 6:09 AM COVID-19 may accelerate progression of presymptomatic type 1 diabetes in youth, a German study suggested.

New Tactic to Speed Long COVID Treatments to Patients

By Staff
Monday, July 15, 2024 8:02 AM Kaila Trawitzki was diagnosed with long COVID in November 2020 and, since then, has never recovered. The Sacramento, California, software engineering consultant said her ongoing symptoms, as well as the cost and risk for travel, make most onsite clinical research trials off limits.

Almost 10% of Infected Pregnant People Develop Long COVID

By Staff
Monday, July 15, 2024 7:59 AM Almost 1 in 10 pregnant people infected with COVID-19 end up developing long COVID, according to a study published in the journal Obstetrics & Gynecology.

Newborn Hep B Vax Refusal Rates Dropped During Pandemic, D.C. Study Finds

By Staff
Friday, July 12, 2024 6:09 AM Fewer mothers in Washington, D.C., refused to have their newborns receive an initial birth dose of the hepatitis B vaccine (Engerix-B, Recombivax HB) in recent years, according to a retrospective study.

How Has the RSV Season Changed Since the Pandemic Began?

By Staff
Wednesday, July 10, 2024 8:02 AM A recent study published in JAMA Network Open described the epidemiological characteristics of respiratory syncytial virus (RSV) infection in Ontario, Canada, after the onset of the COVID-19 pandemic. It is the latest in a series of studies that suggest that virus circulation dynamics and hospitalizations have changed over time. These are crucial pieces of information for managing the seasonal epidemic.

The Most Overlooked Covid Symptom

By Staff
Wednesday, July 10, 2024 6:09 AM Gastrointestinal issues might be the most overlooked COVID symptom. Click here to read more about it.

AstraZeneca's COVID Prevention Drug Application Gets EU Fast-Track Assessment

By Staff
Monday, July 8, 2024 8:02 AM AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorization application for its investigational COVID-19 prevention drug, sipavibart, for an accelerated assessment.

Cold, Flu Virus Can Trigger Long COVID Relapses

By Staff
Friday, July 5, 2024 8:02 AM People who have recovered from long COVID can suffer relapses or flare-ups from new viral infections—not just from COVID but from cold, flu, and other viral pathogens, researchers have found.

A Key Indicator of COVID Just Spiked in the Western U.S.

By Staff
Friday, July 5, 2024 7:59 AM COVID-19 cases have been on the rise nationwide this summer, and now wastewater monitoring data suggests a further increase may be underway in the Western part of the U.S.